Investigation Report on Clopidogrel in China, 2018-2022

Published: July 2018
No. of Pages: 30
Single User License: US $ 2200
Corporate User License: US $ 3300
ReportsandReports

Description

Clopidogrel is a milestone drug in antithrombotic and antiplatelet aggregation. It was approved to be sold on the market by the FDA in 1997. The drug was jointly researched and developed by Bristol-Myers Squibb and Sanofi. Prior to the patent expiration in 2012, Plavix was ranked after Lipitor for many years and was the second best-selling drug in the world. After the patent expired, a global wave of biosimilar boomed.

Clopidogrel was early developed and marketed in China. In 2000, the Clopidogrel of Shenzhen Salubris Pharmaceuticals was first approved for registration under the trade name "Taijia". In Sept. 2000, the Clopidogrel of Sanofi-Aventis and Bristol-Myers Squibb was granted administrative protection in China. In 2001, Sanofi-Aventis's Clopidogrel was approved to be sold in China under the trade name "Plavix". For years, Clopidogrel has been ranking first in China's antithrombotic drug market, with sales revenue exceeding CNY 2 billion in 2017.

The market research, Clopidogrel in the Chinese market is dominated by four companies, namely, Sanofi (Hangzhou) Pharmaceutical Co., Ltd. (Trade Name: Plavix), Shenzhen Salubris Pharmaceutical Co., Ltd. (Trade Name: Taijia), Lepu Pharmaceutical Co., Ltd. (Trade Name: Shuai Tai) and Sanofi (Trade Name: Plavix). According to the sales in 2017, Sanofi (Hangzhou) secured a market share of 52%, ranking first in the Chinese market for a long time.

CRI predicts that with the rising aging population, the change of lifestyle and the increasing incidence of cerebral stroke, myocardial infarction and peripheral arterial thromboembolism, the demand for Clopidogrel in the Chinese market will continue to increase.

Topics Covered:

  • Development History of Clopidogrel in Chinese Market
  • Development Environment of Clopidogrel in China
  • Sales of Clopidogrel in China
  • Major Clopidogrel Manufacturers in Chinese Market
  • Sale Price of Clopidogrel in Chinese Market

Prospects of Chinese Clopidogrel Market, 2018-2022

Published By: China Research and Intelligence
Product Code: China Research and Intelligence1663


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy